Combining chemical synthesis, biological testing, and mass spectrometry into a single integrated workflow could help researchers move more quickly against cancer drug targets.

A new automated workflow developed by scientists at Lawrence Berkeley National Laboratory (Berkeley Lab) has the potential to allow researchers to analyze the products of their reaction experiments in ...

Drug discoverers are among customers Nvidia has pinpointed for its recently launched catalog of pretrained, customizable workflows enabling enterprise-level users to make their own artificial ...

Revvity offers comprehensive solutions designed to help accelerate laboratory workflows, assisting researchers meet targets faster and bring new therapies to market sooner. Our integrated approach ...

Improved content discoverability via Reaxys® Medicinal Chemistry combined with data integration capabilities allow chemists to identify and optimize promising lead candidates Elsevier, a world-leading ...

Workflow Services, a platform to enable pharmacist-led clinical services, has completed a one-year pilot program and is expanding its Colorectal Cancer Screening Education Program. The goal of this ...

Biologics, with their precision targeting, expand treatment options for a multitude of diseases - from cancer to autoimmune disorders. In 2023 alone, 10 antibody therapeutics received their first ...